Company Filing History:
Years Active: 1995-1999
Title: The Innovative Contributions of Jeffrey G. Sarver
Introduction
Jeffrey G. Sarver is a notable inventor based in Rossford, OH (US). He has made significant contributions to the field of medical technology, particularly in the development of bioartificial organs. With a total of 4 patents to his name, Sarver's work is paving the way for advancements in diabetes treatment.
Latest Patents
One of Sarver's latest patents is for a bioartificial pancreas. This implantable device features an islet chamber that contains glucose-responsive and insulin-secreting islets of Langerhans or similar hormone-secreting cells. The device also includes one or more vascularizing chambers that are open to surrounding tissue. A semi-permeable membrane separates the islet and vascularizing chambers, allowing the passage of small molecules such as insulin, oxygen, and glucose while preventing the entry of immune system agents like white cells and antibodies. The vascularizing chambers are designed with a growth factor-soaked fibrous or foam matrix that has a porosity of about 40 to 95%. This matrix promotes small capillary growth and prevents blood clotting in the lower chamber.
Career Highlights
Sarver is affiliated with the University of Toledo, where he continues to innovate and contribute to research in medical technology. His work has garnered attention for its potential to improve the quality of life for individuals with diabetes.
Collaborations
Some of his notable coworkers include Ronald L. Fournier and Peter J. Goldblatt. Their collaborative efforts have further enhanced the research and development of bioartificial organs.
Conclusion
Jeffrey G. Sarver's innovative work in the field of bioartificial organs exemplifies the impact of dedicated inventors on medical technology. His contributions are vital in the ongoing quest to improve healthcare solutions for chronic conditions.